Publication
EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.
Ananth Shankar, Judith Landman-Parker, Maurizio Mascarin, Andishe Attarbaschi, Sabah Boudjemaa, Roberta Burnelli, Auke Beishuizen, Michaela Cepelova, Francesco Ceppi, Thomas Georgi, Georgina Hall, Wolfram Klapper, Regine Kluge, Egesta Lopci, Monika L Metzger, Alan Ramsay, Jonas Steglich, Dietrich Stoevesandt, Lars Kurch, Dieter Körholz, Dirk Hasenclever, Christine Mauz-Körholz
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Children and adolescents with early-stage nodular lymphocyte-predominant Hodgkin lymphoma (nLPHL) have a 5-year event-free survival (EFS) of ∼77% after complete lymph node resection and ∼89% with anthracycline-containing chemotherapy. We investigated whether those patients can be successfully…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerHodgkin Lymphomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available